CQS Cayman’s Elevance Health ELV Stock Holding History

CQS Cayman’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,000	Closed	-$263K	–	141
2016 Q2	$263K	Buy	+2,000	New	+$274K	0.02%	123

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

CQS Cayman's ELV Position: Q3 2016 in Review

CQS Cayman sold out of Elevance Health (ELV) in Q3 2016, closing a stake of 2,000 shares — an estimated $263K sold.

CQS Cayman first reported a position in ELV in Q2 2016 and held it in 1 quarter. The position peaked at $263K in Q2 2016. 737 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

CQS Cayman reported no remaining Elevance Health position as of Q3 2016 after selling out during the quarter.
CQS Cayman sold 2,000 Elevance Health shares in Q3 2016, an estimated $263K.
CQS Cayman first reported a position in Elevance Health in Q2 2016 and held it in 1 quarter.
CQS Cayman's Elevance Health position peaked at $263K in Q2 2016.
737 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on CQS Cayman's 13F filing for Q3 2016, filed 14 Nov 2016.